Correlation Between Okta and Adaptimmune Therapeutics
Can any of the company-specific risk be diversified away by investing in both Okta and Adaptimmune Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Okta and Adaptimmune Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Okta Inc and Adaptimmune Therapeutics Plc, you can compare the effects of market volatilities on Okta and Adaptimmune Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Okta with a short position of Adaptimmune Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Okta and Adaptimmune Therapeutics.
Diversification Opportunities for Okta and Adaptimmune Therapeutics
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Okta and Adaptimmune is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Okta Inc and Adaptimmune Therapeutics Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adaptimmune Therapeutics and Okta is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Okta Inc are associated (or correlated) with Adaptimmune Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adaptimmune Therapeutics has no effect on the direction of Okta i.e., Okta and Adaptimmune Therapeutics go up and down completely randomly.
Pair Corralation between Okta and Adaptimmune Therapeutics
Given the investment horizon of 90 days Okta Inc is expected to generate 0.54 times more return on investment than Adaptimmune Therapeutics. However, Okta Inc is 1.86 times less risky than Adaptimmune Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Adaptimmune Therapeutics Plc is currently generating about -0.01 per unit of risk. If you would invest 6,189 in Okta Inc on August 27, 2024 and sell it today you would earn a total of 1,468 from holding Okta Inc or generate 23.72% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Okta Inc vs. Adaptimmune Therapeutics Plc
Performance |
| Timeline |
| Okta Inc |
| Adaptimmune Therapeutics |
Okta and Adaptimmune Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Okta and Adaptimmune Therapeutics
The main advantage of trading using opposite Okta and Adaptimmune Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Okta position performs unexpectedly, Adaptimmune Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adaptimmune Therapeutics will offset losses from the drop in Adaptimmune Therapeutics' long position.The idea behind Okta Inc and Adaptimmune Therapeutics Plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |